FDA Issues More Product-Specific Bioequivalence Guidances

The FDA has released 23 new draft guidances and revised draft product-specific guidances that detail its recommendations for bioequivalence studies to support ANDAs. Comments on the recommendations are due by Feb. 15.
Generic Line